Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

CAPS Rating: 2 out of 5

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.

Recs

1
Player Avatar pchop123 (76.56) Submitted: 6/27/2012 1:10:50 PM : Outperform Start Price: $8.73 ARNA Score: +29.08

Approved

Featured Broker Partners


Advertisement